FLUTICASONE/ SALMETEROL XINAFOATE INHALER (AirFluSal Forspiro®)

Clinical Indication

COPD and Asthma

Comments

Reviewed by LLR Respiratory Prescribing Group.

Date of classification

February 2017

Review date

February 2017

Black

Drugs not recommended for use in the Leicestershire Health Community because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.

All new drugs will be black until they have been through the appropriate approval process - then they will appear as a specific entry.